A drug with the SMILES NC(=O)CC[C@@H]1NC(=O)[C@H](CO)NC(=O)c2cc([N+](=O)[O-])cc(I)c2NCCC[C@@H](C(N)=O)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O has a human ether-à-go-go related gene (hERG) inhibition at 10uM of -12.750%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
NC(=O)CC[C@@H]1NC(=O)[C@H](CO)NC(=O)c2cc([N+](=O)[O-])cc(I)c2NCCC[C@@H](C(N)=O)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O
NC(=O)CC[C@@H]1NC(=O)[C@H](CO)NC(=O)c2cc([N+](=O)[O-])cc(I)c2NCCC[C@@H](C(N)=O)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O
(6S,9S,12S,15S)-12-(3-amino-3-oxopropyl)-15-(hydroxymethyl)-9-[(4-hydroxyphenyl)methyl]-22-iodo-20-nitro-8,11,14,17-tetraoxo-2,7,10,13,16-pentazabicyclo[16.4.0]docosa-1(18),19,21-triene-6-carboxamide